00512 GRAND PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.14X | Oper Margin | 12.9% |
|---|---|---|---|
| LT Debt/Equity | 11.1% | Net Margin | 10.1% |
| Total Debt/Equity | 27.8% | Return on Equity | 7.3% |
| Price/Book | 1.51X | Return on Assets | 4.6% |
| (HKD 7.220) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 1,240.87 | 2,468.38 | 1,880.00 | 2,079.42 | 2,402.56 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -49.7 | +31.3 | -9.6 | -13.5 | +34.0 |
| Earnings Per Share (HKD) | 0.354 | 0.705 | 0.536 | 0.587 | 0.677 |
| Earnings Per Share Growth (%) | -49.7 | +31.5 | -8.7 | -13.3 | +30.2 |
| Dividend Per Share (HKD) | 0.169 | 0.260 | 0.260 | 0.140 | 0.110 |
| P/E* (X) | 20.37 | 10.24 | 13.47 | 12.30 | 10.66 |
| Yield (%) | 2.34 | 3.60 | 3.60 | 1.94 | 1.52 |
| Dividend Share (%) | 47.69 | 36.88 | 48.51 | 23.85 | 16.24 |
| Book NAV (HKD) | 4.794 | 4.641 | 4.270 | 3.984 | 3.773 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (HKDMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 12,283 | 11,645 | +5.5 | 10,530 |
| Operating Result | 1,418 | 2,704 | -47.6 | 2,369 |
| Associates | 76.059 | 148.72 | -48.9 | -25.008 |
| Profit Before Taxation | 1,494 | 2,852 | -47.6 | 2,344 |
| Taxation | 249.778 | 386.304 | -35.3 | 448.755 |
| Profit /( Loss) After Taxation | 1,244 | 2,466 | -49.6 | 1,895 |
| Minority Interests | 3.432 | -2.316 | -248.2 | 15.444 |
| Net Profit | 1,241 | 2,468 | -49.7 | 1,880 |
| Earnings Per Share () | 0.3544 | 0.7049 | -49.7 | 0.5360 |
| Dividend Per Share () | 0.1690 | 0.2600 | -35.0 | 0.2600 |
| Announcement Date | 2026-03-26 | 2025-03-12 | NA | 2024-03-20 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
